565229-05-2

Basic information

• Product Name: 2H-Pyran-2-one, tetrahydro-4-(methoxymethoxy)-6-[3-[(4-methoxyphenyl)methoxy]propyl]- 3,5-dimethyl-, (3R,4S,5R,6S)-
• CAS NO: 565229-05-2
• Molecular Formula: C20H30O6
• Molecular Weight: 366.455
• Mol File: 565229-05-2.mol

Chemical Properties

• CAS DataBase Reference: 2H-Pyran-2-one, tetrahydro-4-(methoxymethoxy)-6-[3-[(4-methoxyphenyl)methoxy]propyl]- 3,5-dimethyl-, (3R,4S,5R,6S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2H-Pyran-2-one, tetrahydro-4-(methoxymethoxy)-6-[3-[(4-methoxyphenyl)methoxy]propyl]- 3,5-dimethyl-, (3R,4S,5R,6S)-(565229-05-2)
• EPA Substance Registry System: 2H-Pyran-2-one, tetrahydro-4-(methoxymethoxy)-6-[3-[(4-methoxyphenyl)methoxy]propyl]- 3,5-dimethyl-, (3R,4S,5R,6S)-(565229-05-2)

Safety Data

• Hazardous Substances Data: 565229-05-2(Hazardous Substances Data)

Upstream product

• 565229-03-0 (4R)-4-benzyl-3-[(2R,3S,4R,5S)-5-(tert-butyldimethylsilanyloxy)-8-(4-methoxybenzyloxy)-3-methoxymethoxy-2,4-dimethyloctanoyl]oxazolidin-2-one 
• 824-94-2 p-methoxybenzyl chloride 
• 565229-77-8 (4R)-4-benzyl-3-[(2R,3S,4R,5S)-5-(tert-butyldimethylsilanyloxy)-3-hydroxy-8-(4-methoxybenzyloxy)-2,4-dimethyloctanoyl]oxazolidin-2-one 
• 565228-99-1 (4R)-4-benzyl-3-[(2R,3S)-3-(tert-butyldimethylsilanyloxy)-6-(4-methoxybenzyloxy)-2-methylhexanoyl]oxazolidin-2-one 
• 565229-75-6 (4R)-4-benzyl-3-[(2R,3S)-3-hydroxy-6-(4-methoxybenzyloxy)-2-methylhexanoyl]oxazolidin-2-one 
• 565229-76-7 (2S,3S)-3-(tert-butyldimethylsilanyloxy)-6-(4-methoxybenzyloxy)-2-methylhexan-1-ol 
• 119649-27-3 4-((4-methoxybenzyl)oxy)butanal 
• 119649-45-5 4-(p-methoxybenzyloxy)butan-1-ol 
• 565229-01-8 (2R,3S)-3-(tert-Butyl-dimethyl-silanyloxy)-6-(4-methoxy-benzyloxy)-2-methyl-hexanal 

Downstream Products

• 565229-08-5 2(R)-methoxy-6-[(3R,4S,5S,6S)-3-(4-methoxybenzyloxy)propyl]-4-methoxymethoxy-3,5-dimethyltetrahydropran 
• 565228-73-1 (1S,2S,3R,6Z,8S,9S,10S,11Z)-[3,9-bis(4-methoxybenzyloxy)-14-[(2S,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,8,10-trimethyl-1-[(1S,2Z)-1-methylpenta-2,4-dienyl]tetradeca-6,11-dienyloxy]-tert-butyldimethylsilane 
• 565229-72-3 carbamic acid, (1S,2S,3R,6Z,8S,9S,10S,11Z)-3,9-bis(4-methoxybenzyloxy)-14-[(2S,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,8,10-trimethyl-1-[(1S,2Z)-1-methylpenta-2,4-dienyl]tetradeca-6,11-dienyl ester 
• 565228-57-1 carbamic acid, (1S,2S,3R,6Z,8S,9S,10S,11Z)-3,9-bis(4-methoxybenzyloxy)-14-[(2S,3S,4S,5R)-4-methoxymethoxy-3,5-dimethyl-6-oxotetrahydropyran-2-yl]-2,8,10-trimethyl-1-[(1S,2Z)-1-methylpenta-2,4-dienyl]tetradeca-6,11-dienyl ester 
• 565229-82-5 Carbamic acid (6Z,11Z)-(1S,2S,3R,8S,9R,10S)-14-((2S,3S,4S,5R)-4-hydroxy-3,5-dimethyl-6-oxo-tetrahydro-pyran-2-yl)-3,9-bis-(4-methoxy-benzyloxy)-2,8,10-trimethyl-1-((Z)-(S)-1-methyl-penta-2,4-dienyl)-tetradeca-6,11-dienyl ester 
• 565229-96-1 Carbamic acid (6Z,11Z)-(1S,2S,3R,8S,9R,10S)-1-isopropyl-3,9-bis-(4-methoxy-benzyloxy)-14-((2S,3R,4S,5R)-4-methoxymethoxy-3,5-dimethyl-6-oxo-tetrahydro-pyran-2-yl)-2,8,10-trimethyl-tetradeca-6,11-dienyl ester 
• 565229-55-2 carbamic acid, (1S,2S,3R,6Z,8S,9S,10S,11Z)-1-isopropyl-3,9-bis(4-methoxybenzyloxy)-14-[(2R,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,8,10-trimethyltetradeca-6,11-dienyl ester 
• 565229-92-7 (1S,2S,3R,6Z,8S,9S,10S,11Z)-5,11-bis(4-methoxybenzyloxy)-16-[(2R,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,4,10,12-tetramethylhexadeca-8,13-dien-3-ol 
• 565229-47-2 (4S,5R)-4-{(3Z,5S,6S,7S,8Z)-6-(4-methoxybenzyloxy)-11-[(2S,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-5,7-dimethylundeca-3,8-dienyl}-2-(4-methoxyphenyl)-5-methyl[1,3]dioxane 
• 565229-51-8 (2S,3R,6Z,8S,9S,10S,11Z)-3,9-bis(4-methoxybenzyloxy)-14-[(2S,3S,4S,5R,6R)-6-methoxy-4-methoxymethoxy-3,5-dimethyltetrahydropyran-2-yl]-2,8,10-trimethyltetradeca-6,11-dienal 

Relevant articles and documents

ANALOGS OF DISCODERMOLIDE AND DICTYOSTATIN-1, INTERMEDIATES THEREFOR AND METHODS OF SYNTHESIS THEREOF

A compound of the following structure: wherein R1 is H, an alkyl group, an aryl group, an alkenyl group, an alkynyl group, or a halogen atom; R2 is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; Ra, Rb and Rc are independently an alkyl group or an aryl group; Rd is an alkyl group, an aryl group, an alkoxylalkyl group, -RiSiRaRbRc or a benzyl group, wherein Ri is an alkylene group; Re is an alkyl group, an allyl group, a benzyl group, an aryl group, an alkoxy group, or -NRgRh, wherein Rg and Rh are independently H, an alkyl group or an aryl group; R3 is (CH2)n where n is and integer in the range of 0 to 5, -CH2CH(CH3)-, -CH=CH-, -CH=C(CH3)-, or -C=-C-; R4 is (CH2)p where p is an integer in the range of 4 to 12, -(CHRkl)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5C(Rsl )=C(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1 )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(RsI)CH(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRks)y5C(Rsl)=C(Rs2)CH(Rs3)CH(Rs4)-, -(CHRkI )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rsl)CH(Rs2)CH(Rs3)CH(R s4)-,wherein y1 and y2 are 1 and y3, y4 and y5 are independently 0 or 1, Rk1, Rk2, Rk3, Rk4 and Rk5 are independently H, CH3, or OR2a, and Rs1,Rs2, Rs3, and Rs4 are independently H or CH3, wherein R2a is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; and R5 is H or OR2b, wherein R2b is H, an alkyl group, an aryl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; provided that the compound is not dictyostatin 1.

Simplified discodermolide analogues: Synthesis and biological evaluation of 4-epi-7-dehydroxy-14,16-didemethyl-(+)-discodermolides as microtubule-stabilizing agents

Several novel analogues of (+)-discodermolide were synthesized via a convergent strategy that used Wittig reactions to append left and right side chains to a central scaffold and then tested for biological activity. Three of the analogues in the 4-epi-7-d